Disorder "Cystic fibrosis"
Found 271 records
Disorder information
Disorder name:
Cystic fibrosis 
Disoder ID:
OMIM entry:
Synonyms:
CF,mucoviscidosis 
Definition:
Cystic fibrosis (CF) is a genetic disorder characterized by the production of sweat with a high salt content and mucus secretions with an abnormal viscosity. 
Modifier statisitcs
Record:
271 
Gene:
86 
Variant:
197 
Reference:
76 
Effect type:
Expressivity(157) ,Pleiotropy(82) ,Penetrance(32)  
Modifier effect:
Altered severity(64) ,Altered phenotype(52) ,Risk factor(44) ,Altered incidence(30) ,Altered FEV1 level(12) ,Altered lung function(7) ,Altered life span(6) ,Altered the contributing organ(5) ,Altered susceptibility(4) ,Altered FEV(1)(4) ,CFTR mediated residual chloride secretion(4) ,Altered Ca2+-influx(3) ,Altered Pseudomonas aeruginosa colonization rate(3) ,Altered onset time(3) ,Age-adjusted lung function(2) ,Altered CF-associated pulmonary inflammation(2) ,Altered gene activity(2) ,Altered onset time of P. aeruginosa airway infection(2) ,Altered pulmonary function(2) ,Altered epithelial chloride secretion(1) ,Altered lung disease progression(1) ,Altered RhoA activity(1) ,Altered X ray score (Chrispin-Norman) and Shwachman score(1) ,Altered acute phase levels(1) ,Altered airway nitric oxide formation(1) ,Altered annual rate of FEV1(1) ,Altered chance of developing portal hypertension(1) ,Altered forced vital capacity and risk of MI or DIOS(1) ,Altered gene activity and Altered severity(1) ,Altered intestinal secretion(1) ,Altered onset time and altered severity(1) ,Altered pulmonary prognosis(1) ,Altered rates of CFRD(1) ,Altered response to pulmonary infection with Pa(1) ,Altered risk of chronic Pseudomonas aeruginosa infection(1) ,Altered variability of FENO and P. aeruginosa colonization(1) ,Anti-inflammatory target(1) ,Prevention of disease(1) ,Protective effect against severe pulmonary disease(1)  
Modifier gene Variant Effect type Modifier effect Evidence Effect PubMed ID
SERPINA1 SERPINA1:c.1096G>A(p.Glu366Lys) Expressivity  Altered severity  OR=4.72; 95% CI: 2.31-9.61; P=3.3×10(-6)  Patients who carry the Z allele are at greater risk of developing severe liver disease with portal hypertension.more more
SERPINA1:c.1237G>A Expressivity  Altered acute phase levels  From review article  1237G>A in the 3′untranslated region, which may result in a decrease in acute phase levelsmore more
SERPINA1:c.4627G>A Expressivity  Altered severity  Gene activity study  Deficiency of alpha 1-AT is not associated with more severe pulmonary disease in cystic fibrosis and may be associated with milder lung disease.more more
SERPINA1:c.863A>T(p.Glu288Val) Expressivity  Altered severity  Gene activity study  Deficiency of alpha 1-AT is not associated with more severe pulmonary disease in cystic fibrosis and may be associated with milder lung disease.more more
SERPINA1:p.Glu264Val Expressivity  Altered severity  From review article  Glu264Val or c2313T>A and Glu342Lys or c4627G>A reduced plasma levels of α1-antitrypsin,affect lung disease or nutritional status and have mixed results regarding infection status and liver disease.more more
SERPINA1:p.Glu342Lys Expressivity  Altered severity  From review article  Glu264Val or c2313T>A and Glu342Lys or c4627G>A reduced plasma levels of α1-antitrypsin,affect lung disease or nutritional status and have mixed results regarding infection status and liver disease.more more
SERPINA1:p.Gly264Val Expressivity  Risk factor  From review article  The mutation associated with Gilbert syndrome represents a lithogenic risk factor for gallstone formation in CFmore more
SERPINA1:p.Gly342Leu Expressivity  Risk factor  From review article  The mutation associated with Gilbert syndrome represents a lithogenic risk factor for gallstone formation in CFmore more
SERPINA1 Pleiotropy  Altered Pseudomonas aeruginosa colonization rate  From review article  Higher FEV1 and fewer colonized with Pseudomonas aeruginosa for deficient patientsmore more
SERPINA1 Expressivity  Risk factor  From review article  Association observed in ≥2 independent populations with ≥500 participants in aggregatemore more
Total 271,Each Page
,Jump To
Page